Metformin Mitigated Obesity-Driven Cancer Aggressiveness in Tumor-Bearing Mice

Metformin may offer benefits to certain cancer populations experiencing metabolic abnormalities. To extend the anticancer studies of metformin, a tumor model was established through the implantation of murine Lewis Lung Carcinoma (LLC) cells to Normal Diet (ND)-fed and High-Fat Diet (HFD)-fed C57BL/...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Jung, Wu, Chih-Cheng, Chang, Cheng-Yi, Li, Jian-Ri, Ou, Yen-Chuan, Chen, Wen-Ying, Liao, Su-Lan, Wang, Jiaan-Der
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408975/
https://www.ncbi.nlm.nih.gov/pubmed/36012397
http://dx.doi.org/10.3390/ijms23169134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408975/
https://www.ncbi.nlm.nih.gov/pubmed/36012397
http://dx.doi.org/10.3390/ijms23169134

Ejemplares similares